Introduction {#Sec1}
============

Regardless of the exact criteria used to define it, oliguria is often observed in critically ill patients, and yet there are many questions regarding its clinical relevance and impact on outcomes. Reduced urine output can be a physiological response or a reflection of altered tissue perfusion or renal dysfunction \[[@CR1]--[@CR3]\].

Although urine output is now widely used as one of the criteria for the diagnosis and staging of acute renal failure \[[@CR4]--[@CR7]\], there are relatively few studies that have specifically assessed urine output or oliguria as a marker of acute renal failure or outcomes in general populations of intensive care unit (ICU) patients \[[@CR2], [@CR8], [@CR9]\]. The clinical importance of oliguria likely depends on its duration. For example, a 1-h period of oliguria during an emergency admission is less important than if the symptom persists for longer periods, when it is more likely to reflect impaired renal function \[[@CR10], [@CR11]\].

To provide some global insight into the impact of oliguria and its persistence on outcomes in general ICU patients, we reviewed the large, international Intensive Care over Nations (ICON) database to evaluate the occurrence of oliguria and its association with the need for renal replacement therapy (RRT) and mortality.

Patients and methods {#Sec2}
====================

This study is a substudy of the ICON audit \[[@CR12]\]. All adult (\> 16 years) patients admitted to a participating ICU (see the list in the "Acknowledgements") between May 8 and May 18, 2012, were included in the audit, except those who stayed in the ICU for \< 24 h for routine postoperative surveillance. Participation was voluntary, with no financial incentive. Ethics committee approval was obtained by the participating institutions according to local ethical regulations.

Data were collected daily for a maximum of 28 days in the ICU and entered using electronic case report forms via a secured internet-based website. Survival data were collected at the time of ICU and hospital discharge, or at 60 days, whichever occurred first. Detailed instructions and definitions were available through a secured website for all participants before starting data collection and throughout the study period. Any additional queries were answered on a per case basis. Validity checks were made at the time of electronic data entry, including plausibility checks within each variable and between variables. Data were further reviewed by the coordinating center for completeness and plausibility, and any doubts clarified with the participating center. There was no on-site monitoring.

Data collection on admission included demographic data and comorbidities. Clinical and laboratory data for the SAPS II score \[[@CR13]\] were reported as the worst values within the first 24 h after admission. A daily evaluation of organ function was performed according to the Sequential Organ Failure Assessment (SOFA) score \[[@CR5]\]; organ failure was defined as a SOFA subscore \> 2 for the organ in question. ICU interventions, including RRT and mechanical ventilation, were recorded daily.

Clinical and microbiologically proven infections were reported daily as well as antimicrobial therapy. Infection was defined according to the criteria of the International Sepsis Forum \[[@CR14]\]. Sepsis was defined as the presence of infection with associated organ failure \[[@CR15]\]. Septic shock was defined as sepsis associated with cardiovascular failure requiring vasopressor support (SOFA cardiovascular score ≥ 3). The presence of a decision to withhold/withdraw a life-sustaining measure at any time during the ICU stay was also recorded.

On the case report form, investigators recorded urine output in milliliters as a total for each 24-h period. On the day of admission, urine output data were recorded for the period from the time of admission till the start of the next ICU day. For the purposes of this study, oliguria was defined as a calculated urine output \< 0.5 ml/kg/h averaged over a 24-h period \[[@CR2]\]. To calculate the urine output for the 24-h admission day period, if full urine output data for the first 24 h of admission were recorded, these data were used for the determination of oliguria "on admission." If data were provided for only *X* hours on the day of admission (because, for example, the patient was admitted at 10 pm and 24-h urine measurement started at midnight so only 2-h urine output were noted), the estimation of urine output on admission was averaged from the data for the *X* hours and the data from the first full day on the ICU (2nd day 24-h urine output/24 × \[24 − *X*\]). If no data were recorded for the admission day, we were unable to estimate an admission urine output and the patient was not included. The methods of measuring urine output or of assessing body weight were not recorded. Patients with comorbid chronic renal failure were excluded.

For analysis of evolution during the ICU stay, we included only patients who had a urine output recorded on the day of admission and at least one other 24-h urine output value, and separated them into three groups: Transient oliguria---oliguria resolved within 48 h after the 24-h admission dayProlonged oliguria---oliguria resolved more than 48 h after the 24-h admission day and not present at the end of the ICU stayPermanent oliguria---oliguria present on the day of admission and persisting for the whole ICU stay or again present at the end of the ICU stay

Statistical analysis {#Sec3}
--------------------

Data are shown as means with standard deviation (SD) or 95% confidence intervals (CI), medians and interquartile ranges (IQR), numbers, and percentages. For the descriptive statistics, only available data were used so missing data were subtracted from the denominator when calculating percentages. Differences between groups in distribution of variables were assessed using the analysis of variance (ANOVA), Kruskal-Wallis test, Student's *t* test, Mann-Whitney test, chi-square test, or Fisher's exact test as appropriate.

Individual countries were classified into three income groups according to the 2011 gross national income (GNI) per capita, calculated using the World Bank Atlas method \[[@CR16]\]: GNI \< \$4035 = low and lower middle income, GNI \$4036--12,475 = upper middle income, and GNI \> \$12,476 = high income.

To investigate the association between oliguria on admission and mortality, we used a three-level technique with the structure of an individual patient (level 1) admitted to a specific hospital (level 2) within a particular country (level 3). So patients were nested within hospitals within countries. The model includes hospital and country units as random effects to express the concept that patients from the same country and treated in the same hospital share a common environment. The dependency between patients in a hospital within a country is captured through the use of random intercepts. The explanatory variables considered in the model were: Individual-level factors: age, sex, SAPS II score, type of admission, source of admission, highest concentration of creatinine, daily fluid balance, mechanical ventilation or RRT at any time during the ICU stay, fluid balance, presence of recorded end-of-life decision, comorbidities, severity of sepsis during the ICU stay, oliguria on admissionHospital-level factors: type of hospital, ICU specialty, total number of ICU patients in the previous year, number of staffed ICU bedsCountry-level factors: GNI

Collinearity between variables was checked by inspection of the correlation between them, by looking at the correlation matrix of the estimated parameters, and by looking at the change in parameter estimates and at their estimated standard errors \[[@CR17]\]. Q-Q plots were drawn to check for normality in the residuals. The results of fixed effects (measures of association) are given as odds ratios (OR) with their 95% CI. Random effects (measures of variation) measures included the variance (var) and its standard error (se). The restricted maximum likelihood (REML) procedure, which gives unbiased estimates of the model parameters, was used. The Wald test was used to assess the significance of included covariates. The percentage of cases correctly classified and the area under the receiver operating characteristic curve (AUC) are given to quantify the discriminating power of the model. Missing cases for the included variables were analyzed using the missing-value indicator method.

Data were analyzed using IBM® SPSS® Statistics software, version 26 for Windows and R software, version 3.6.1 (CRAN project). All reported *p* values are two-sided, and a *p* value \< 0.05 was considered to indicate statistical significance.

Results {#Sec4}
=======

Of the 10,069 patients included in the ICON audit, 9148 had urine output data on the day of admission; 856 had comorbid chronic renal failure and were excluded, leaving 8292 patients for analysis (Fig. [1](#Fig1){ref-type="fig"}). Fig. 1Flow chart of patients included in study

Patients with oliguria on admission {#Sec5}
-----------------------------------

A total of 2050 (24.7%) patients had oliguria on the 24-h admission period, with a median urine output of 0.3 \[IQR 0.1--0.4\] ml/kg/h compared to 1.1 \[IQR 0.8--1.6\] ml/kg/h in patients who were not oliguric on admission (*p* \<  0.001) (Table [1](#Tab1){ref-type="table"}). Patients with oliguria on admission were older and more severely ill than those without, and a higher proportion had a medical diagnosis and comorbid heart failure, liver cirrhosis, and human immunodeficiency virus (HIV) infection (Table [1](#Tab1){ref-type="table"}). They were more likely to have sepsis (24.5% vs 16.7%, *p* \<  0.001) and to have all forms of organ failure, except hepatic (Table [1](#Tab1){ref-type="table"}). Vasopressor use was higher in patients with oliguria at admission than in those without (36.9% vs 26.8%, *p* \<  0.001). Table 1Characteristics of the study cohort on admission to the ICU stratified according to whether or not oliguria was presentAll patients ***n*** = 8292Oliguria at admission***p*** valueNo\
***n*** = 6242 (75.3%)Yes\
***n*** = 2050 (24.7)Urine output (ml/kg/h) median \[IQR\]0.9 \[0.5--1.4\]1.1 \[0.8--1.6\]0.3 \[0.1--0.4\]\< 0.001Age, years, mean ± SD59.2 ± 18.258.1 ± 18.362.5 ± 17.4\< 0.001Male, *n* (%)4928 (60.0)3724 (60.2)1204 (59.4)0.55Severity scores, mean ± SD SAPS II score40.8 ± 17.537.9 ± 15.149.8 ± 20.8\< 0.001 SOFA score at admission6.2 ± 4.25.7 ± 3.87.6 ± 5.0\< 0.001 SOFA score at admission (without renal subscore)5.3 ± 3.75.1 ± 3.55.8 ± 4.2\< 0.001Type of admission, *n* (%) Surgical (non-trauma)2939 (37.2)2374 (39.9)565 (29.2)\< 0.001 Medical4335 (54.9)3063 (51.4)1272 (65.7) Trauma569 (7.2)478 (8.0)91 (4.7) Other48 (.6)40 (.7)8 (.4)Source of admission, *n* (%) Other hospital825 (9.9)625 (10.0)200 (9.8)\< 0.01 ER/ambulance3151 (38.0)2336 (37.4)815 (39.8) OR/recovery room1569 (18.9)1304 (20.9)265 (12.9) Hospital floor2117 (25.5)1529 (24.5)588 (28.7) Other630 (7.6)448 (7.2)182 (8.9)Comorbidities, *n* (%) COPD1012 (12.2)737 (11.8)275 (13.4)0.06 Cancer891 (10.7)684 (11.0)207 (10.1)0.29 Metastatic cancer288 (3.5)205 (3.3)83 (4.0)0.11 Hematologic cancer178 (2.1)126 (2.0)52 (2.5)0.16 Insulin682 (8.2)496 (7.9)186 (9.1)0.12 Heart failure, NYHA III/IV648 (7.8)445 (7.1)203 (9.9)\< 0.001 HIV infection56 (.7)33 (.5)23 (1.1)\< 0.01 Cirrhosis283 (3.4)188 (3.0)95 (4.6)\< 0.001 Immunosuppression259 (3.1)184 (2.9)75 (3.7)0.11 Steroid therapy273 (3.3)208 (3.3)65 (3.2)0.78 Chemotherapy239 (2.9)181 (2.9)58 (2.8)0.94Organ support, *n* (%) Mechanical ventilation4227 (51.0)3184 (51.0)1043 (50.9)0.92 Renal replacement therapy321 (3.9)97 (1.6)224 (10.9)\< 0.001 Vasopressor use2429 (29.3)1672 (26.8)757 (36.9)\< 0.001Type of organ failure, *n* (%) (alone or in combination) Respiratory1867 (22.5)1334 (21.4)533 (26.0)\< 0.001 Coagulation530 (6.4)345 (5.5)185 (9.0)\< 0.001 Hepatic885 (10.7)658 (10.5)227 (11.1)0.51 CNS1972 (23.8)1435 (23.0)537 (26.2)\< 0.01 Renal1341 (16.2)524 (8.4)817 (39.9)\< 0.001 Cardiovascular2296 (27.7)1580 (25.3)716 (34.9)\< 0.001Number of organ failures, *n* (%) None1771 (21.4)1489 (23.9)282 (13.8)\< 0.001 1 organ2344 (28.3)1805 (28.9)539 (26.3) 2 organs1693 (20.4)1302 (20.9)391 (19.1) 3 organs1231 (14.8)883 (14.1)348 (17.0) \> 3 organs1253 (15.1)763 (12.2)490 (23.9)Sepsis, *n* (%)1543 (18.6)1041 (16.7)502 (24.5)\< 0.001ICU stay, median \[IQR\]3.0 \[2.0--6.0\]3.0 \[2.0--6.0\]3.0 \[1.0--7.0\]\< 0.001 In survivors3.0 \[1.0--6.0\]3.0 \[1.0--6.0\]3.0 \[0.0--7.0\]0.046 In non-survivors3.0 \[0.0--8.0\]5.0 \[1.0--10.0\]2.0 \[0.0--6.0\]\< 0.001Hospital stay, median \[IQR\]10.0 \[5.0--20.0\]10.0 \[6.0--20.0\]8.0 \[2.0--18.0\]\< 0.001 In survivors11.0 \[2.0--21.0\]11.0 \[2.0--21.0\]11.0 \[1.0--22.0\]0.075 In non-survivors5.0 \[0.0--14.0\]7.0 \[1.0--15.0\]3.0 \[0.0--10.0\]\< 0.001ICU mortality, *n* (%)1234 (15.2)700 (11.5)534 (26.8)\< 0.001Hospital mortality, *n* (%)1649 (21.1)983 (16.7)666 (34.5)\< 0.001*SD* standard deviation, *SAPS II* Simplified Acute Physiology Score II, *SOFA* Sequential Organ Failure Assessment, *ER* emergency room, *OR* operating room, *COPD* chronic obstructive pulmonary disease, *NYHA* New York Heart Association, *HIV* human immunodeficiency virus, *CNS* central nervous system, *ICU* intensive care unit, *IQR* interquartile range. Percentages are calculated after excluding missing data

ICU (26.8% vs 11.5%, *p* \<  0.001) and hospital (34.5% vs 16.7%, *p* \<  0.001) mortality rates were more than twice as high in patients with oliguria on admission than in those without (Table [1](#Tab1){ref-type="table"}). End-of-life decisions were more common in oliguric patients than in the other patients (Table [2](#Tab2){ref-type="table"}). Table 2Interventions and occurrence of sepsis during the ICU stayAll patients\
***n*** = 8292Oliguria***p*** valueNo\
***n*** = 6242 (75.3%)Yes\
***n*** = 2050 (24.7%)Creatinine, highest concentration (mg/dl), median \[IQR\]1.0 \[0.8--1.5\]0.9 \[0.7--1.3\]1.3 \[0.9--2.4\]\< 0.001Daily fluid balance^a^, ml, median \[IQR\]81.0 \[− 504.1--730.4\]3.3 \[− 612--605.7\]356.3 \[− 153.2--1116.7\]\< 0.001Mechanical ventilation, *n* (%)4769 (57.5)3579 (57.3)1190 (58.0)0.59RRT, *n* (%)849 (10.2)407 (6.5)442 (21.6)\< 0.001 Hemofiltration, *n* (%)590 (7.1)268 (4.3)322 (15.7)\< 0.001 Hemodialysis, *n* (%)551 (6.6)266 (4.3)285 (13.9)\< 0.001Sepsis severity, *n* (%) No sepsis5718 (69)4403 (70.5)1315 (64.1)\< 0.001 Sepsis1104 (13.3)858 (13.7)246 (12.0) Shock1470 (17.7)981 (15.7)489 (23.9)Decision to withhold/withdraw life-sustaining therapy, *n* (%)1068 (12.9)728 (11.7)340 (16.6)\< 0.001^a^Total fluid balance divided by the length of ICU stay. *RRT* renal replacement therapy

RRT was needed at some point during the ICU stay in 442 (21.6%) of the patients with and in 407 (6.5%) of the patients without oliguria on admission (*p* \<  0.001) (Table [2](#Tab2){ref-type="table"}). Multilevel analysis revealed that the need for RRT was associated with a statistically significant increased risk of death (OR = 1.51 \[95% CI 1.19--1.91\], *p* = 0.001), but the presence of oliguria on admission was not (OR = 1.14 \[95% CI 0.97--1.34\], *p* = 0.103) (Table [3](#Tab3){ref-type="table"}). After controlling for patient and hospital factors and GNI, there was significant between-hospital (var = 0.5 \[se = 0.09\], *p* \<  0.001) and between-country (var = 0.23 \[se = 0.08\], *p* = 0.004) variation in risks of in-hospital death (Table [3](#Tab3){ref-type="table"}), indicating that the occurrence of in-hospital death was influenced by both hospital- and country-related factors. Table 3Multilevel analysis of factors associated with hospital mortalityVariablesOR (95% CI)***p*** valueFixed effects, varying within clusters Age1.00 (1.00--1.01)0.19 Sex, male0.99 (0.85--1.14)0.848 SAPS II1.05 (1.05--1.06)\< 0.001 Type of admission (%)  SurgicalRefna  Medical1.53 (1.26--1.86)\< 0.001  Trauma1.53 (1.14--2.05)0.004  Other1.92 (0.71--5.17)0.196 Source of admission  OR/recoveryRefna  Other hospital1.17 (0.81--1.68)0.404  ER/ambulance1.12 (0.84--1.49)0.458  Hospital floor1.65 (1.26--2.16)\< 0.001  Other1.20 (0.81--1.80)0.366 Comorbidities  COPD0.98 (0.73--1.31)0.877  Cancer1.41 (1.15--1.74)0.001  Metastatic cancer1.20 (0.86--1.67)0.281  Hematologic cancer1.75 (1.25--2.44)0.001  Insulin0.84 (0.64--1.09)0.189  Heart failure, NYHA III/IV1.54 (1.19--1.99)0.001  HIV infection0.73 (0.27--1.94)0.523  Cirrhosis2.12 (1.45--3.10)\< 0.001  Immunosuppression1.19 (0.78--1.79)0.419  Steroid therapy1.17 (0.74--1.84)0.497  Chemotherapy0.92 (0.55--1.53)0.748 Creatinine, highest \[mg/dl\]1.00 (0.97--1.02)0.796 Daily fluid balance^a^ \[l\]1.37 (1.25--1.50)\< 0.001 Procedures during the ICU stay  Mechanical ventilation2.66 (2.12--3.34)\< 0.001  Renal replacement therapy1.51 (1.19--1.91)0.001 Severity of sepsis  No sepsisRefna  Sepsis without shock0.98 (0.75--1.28)0.887  Septic shock1.55 (1.25--1.92)\< 0.001 End-of-life decision11.82 (6.70--20.84)\< 0.001 Oliguria on admission1.14 (0.97--1.34)0.103Fixed effects, constant within clusters Type of hospital  University/academicRefna  Non-university1.16 (0.88--1.52)0.293 Number of patients admitted to the ICU (in 2011)  750+Refna  500--7490.95 (0.76--1.19)0.663  250--4990.95 (0.68--1.31)0.746  \< 2501.21 (0.77--1.91)0.415 ICU specialty  SurgicalRefna  Medical0.63 (0.38--1.04)0.072  Mixed0.73 (0.54--1.00)0.047  Others0.94 (0.58--1.52)0.79 Staffed ICU beds  15+Refna  \< 151.12 (0.87--1.44)0.397 Income  HighRefna  Upper middle1.81 (1.20--2.73)0.005  Low and lower middle2.05 (1.37--3.08)0.001Random effects Country  Variance (se)0.23 (0.08)*p* value0.004 Hospital within country  Variance (se)0.50 (0.09)*p* value\< 0.001^a^Total fluid balance divided by the length of ICU stay*OR* odds ratio, *SAPS II* Simplified Acute Physiology Score II, *ER* emergency room, *OR* operating room, *COPD* chronic obstructive pulmonary disease, *NYHA* New York Heart Association, *HIV* human immunodeficiency virus. The percentage of cases correctly classified with this model is 88.6%. The AUC is 91.5% (95% CI 90.7--92.3%)

Persistence of oliguria during ICU stay {#Sec6}
---------------------------------------

A total of 1349 patients had at least one additional urine output measurement recorded during their ICU stay. Oliguria was transient in 390 (28.9%) of these patients, prolonged in 141 (10.5%), and permanent in 818 (60.6%) (Table [4](#Tab4){ref-type="table"}). ICU mortality was 7.1% when oliguria was transient, significantly lower than in the patients without oliguria (11.5%, *p* = 0.037); rates were 10.9% when oliguria was prolonged and 28.9% when permanent (Table [4](#Tab4){ref-type="table"}). Table 4Creatinine concentrations, fluid balance, renal replacement therapy, and mortality rates in patients with transient, prolonged, and permanent oliguriaNon-oliguric on admission\
***n*** = 6242Oliguria during ICU stay, ***n*** = 1349***p*** value (across groups)Transient\
***n*** = 390 (28.9%)Prolonged\
***n*** = 141 (10.5%)Permanent\
***n*** = 818 (60.6%)SAPS II score, mean ± SD37.9 ± 15.147.1 ± 16.7^£^54.4 ± 17\*^,£^49.7 ± 18.8^\$,£^\< 0.001Creatinine, highest concentration (mg/dl), median \[IQR\]0.9 \[0.7--1.3\]1.2 \[0.8--2.1\]^£^1.6 \[1.1--3.4\]\*^,£^1.5 \[0.9--2.8\]\*^,£^\< 0.001Daily fluid balance^a^, ml, median \[IQR\]3.3 \[−612--605.7\]49.9 \[− 521--650\]105.0 \[− 541.3--780.1\]308.9 \[− 171.5--1123.7\]\*^,\$,£^\< 0.001RRT at admission, *n* (%)97 (1.6)22 (5.6)^£^31 (22)\*^,£^121 (14.8)\*^,£^\< 0.001RRT during ICU stay, *n* (%)407 (6.5)48 (12.3)^£^63 (44.7)\*^,£^273 (33.4)\*^,\$,£^\< 0.001ICU mortality, *n* (%)700 (11.5)27 (7.1)^£^15 (10.9)232 (28.9)\*^,\$,£^\< 0.001 In non RRT patients, *n* (%)580 (10.2)22 (6.6)8 (10.7)102 (19.1)\*^,£^\< 0.001 In RRT patients, *n* (%)120 (29.9)5 (10.9)^£^7 (11.3)^£^130 (48.3)\*^,\$,£^\< 0.001End-of-life decision, *n* (%)728 (11.7)47 (12.1)12 (8.5)163 (19.9)\*^,\$,£^\< 0.001 In non RRT patients, *n* (%)650 (11.1)43 (12.6)8 (10.3)86 (15.8)^£^0.012 In RRT patients, *n* (%)78 (19.2)4 (8.3)4 (6.3)77 (28.2)\*^,\$,£^\< 0.001Hospital mortality, *n* (%)983 (16.7)53 (14.7)33 (24.8)\*296 (37.7)\*^,\$,£^\< 0.001Pairwise *p* values: \*vs transient; ^\$^vs prolonged; ^£^vs non-oliguric on admission. ^a^Total fluid balance divided by the length of ICU stay. *IQR* interquartile range, *RRT* renal replacement therapy, *ICU* intensive care unit. Percentages are calculated after excluding missing data

RRT was used in the ICU in 48 (12.3%), 63 (44.7%), and 273 (33.4%) patients with transient, prolonged, and permanent oliguria, respectively; 102 (19%) patients with permanent oliguria died in the ICU without receiving RRT. RRT was started within 24 h in 72.4% of patients with oliguria (75.0% vs 73.0% vs 71.8% in patients with transient, prolonged, and permanent oliguria, respectively). Among patients receiving RRT, ICU mortality was higher in non-oliguric patients than in those with transient or prolonged oliguria but lower than in those with permanent oliguria (Table [4](#Tab4){ref-type="table"}). The maximum serum creatinine concentration was higher in patients with prolonged and permanent oliguria than in those with transient oliguria (Table [4](#Tab4){ref-type="table"}). The mean daily fluid balance during the ICU stay was significantly higher in patients with permanent oliguria than in those with transient or prolonged oliguria (Table [4](#Tab4){ref-type="table"}).

Discussion {#Sec7}
==========

The present study in a large cohort of ICU patients with urine outputs measured on admission and during the ICU stay reveals that oliguria is present in about one fourth of critically ill patients on admission to the ICU. The presence of oliguria on admission was not independently associated with an increased risk of death, but the persistence of oliguria during the ICU stay was associated with higher ICU and hospital mortality rates.

There are relatively few published data on the frequency of oliguria in general ICU patients. Oliguria is frequently observed in the perioperative period and may be the consequence of hypovolemia and/or pain, both triggering the sympathetic nervous system, which in turn lead to activation of the renin-angiotensin-aldosterone system with ensuing oliguria. However, oliguria may also represent a warning of deteriorating renal function, especially in critically ill patients. Macedo et al. reported that 47% of their cohort of 317 surgical ICU patients had an episode of oliguria (urine output \< 0.5 ml/kg/h for at least 6 consecutive hours) during the ICU stay \[[@CR1]\]. In an analysis of data from the FINNAKI study, as many as 92% of patients had an episode of oliguria as defined by a urine output \< 0.5 ml/kg/h for a minimum of 0.5 h \[[@CR3]\]. From their large database, Kellum et al. reported that 59% of ICU patients with acute kidney injury (AKI) met the KDIGO urine output criteria \[[@CR8]\]. In a smaller cohort, Md Ralib et al. reported that 61% of patients with AKI met urine output criteria (\< 0.5 ml/kg/h) \[[@CR11]\], and in a study of critically ill cancer patients, 56% met urine output criteria for AKI \[[@CR18]\].

The mortality rate was higher in patients with oliguria than in those without. In an analysis of 21,207 ICU patients from the large MIMIC-II database, Zhang et al. similarly reported increased mortality in patients with oliguria on day 1 \[[@CR19]\]. However, oliguria may be an epiphenomenon of or surrogate for disease severity and after adjusting for multiple factors in the multilevel analysis, oliguria on admission was not independently associated with increased mortality in our patients. Importantly, we also analyzed the persistence of oliguria during the ICU stay and noted that ICU mortality rates in patients with transient oliguria were significantly lower than those in non-oliguric patients. Indeed, ICU and hospital mortality rates were lower in these patients with transient oliguria than in the overall ICON cohort (ICU 16.2%, hospital 22.4%, both *p* \<  0.001) \[[@CR12]\]. Our results therefore highlight that the duration of oliguria seems to be more important than the presence of oliguria per se. Macedo et al. similarly reported that prolonged duration of oliguria (\> 12 h) was associated with increased mortality \[[@CR1]\]. Vaara et al. \[[@CR3]\] reported that 6--12 h of oliguria (0.3 to \< 0.5 ml/kg/h), \> 6 h of oliguria (0.1 to \< 0.3 ml/kg/h), and severe oliguria (\< 0.1 ml/kg/h) lasting \> 3 h were independently associated with increased 90-day mortality. In an earlier analysis of the ICON database, patients who remained in stage 3 AKI (defined using the AKIN urine output or creatinine criteria) for a 7-day period had higher mortality rates than those in whom renal function recovered \[[@CR20]\]. Prowle et al. \[[@CR2]\] noted that although oliguria of longer than 1 h was significantly associated with the subsequent development of AKI diagnosed using creatinine criteria, short periods (1--6 h) of oliguria were not accurate at predicting AKI. In a cohort of patients undergoing major abdominal surgery, the presence of oliguria (urine output \< 0.3 ml/kg/h) during surgery was indicative of an elevated probability of later AKI \[[@CR21]\]. Similar results were recently published by Myles et al. \[[@CR22]\] when a urine output \< 0.5 ml/kg/h was used to define oliguria.

Our data also suggest that the increased mortality may be related more to the need for RRT than the oliguria itself, suggesting that other parameters, for example, high serum creatinine concentrations, may be better indicators for RRT than urine output. In an analysis of the MIMIC-II database, Mandelbaum et al. \[[@CR9]\] reported that the increase in serum creatinine was a better predictor of the need for RRT than urine output, although urine output was a slightly better predictor of mortality. In their analysis, Kellum et al. reported that RRT use was more likely in patients diagnosed with AKI using urine output and creatinine concentration criteria than in patients diagnosed with AKI using just one of the two criteria \[[@CR8]\]. We did not use the AKI criteria, preferring to use the more global term of "acute renal failure" (defined by a renal SOFA score \> 2) and need for RRT, because this puts the degree of renal impairment in relation to the dysfunction of the other organs. The SOFA criteria are actually more commonly used than AKI in the critical care literature \[[@CR23]\]. Somewhat surprisingly, in the current analysis, RRT was used in only 33% of the patients with permanent oliguria; however, 66% of the patients with permanent oliguria who did not receive RRT were discharged to the hospital floor or another hospital and we have no information about ongoing patient management after ICU discharge. Patients with permanent oliguria were also more likely to have a recorded decision to withhold/withdraw a life-sustaining measure, possibly explaining why RRT was not used in some of these patients.

Recovery of a urine output is not itself a predictive factor, and urine output is not helpful in guiding fluid resuscitation \[[@CR24]\]. Patients with permanent oliguria had a more positive fluid balance than those with transient or prolonged oliguria, which may explain in part the higher mortality rates in these patients, although it is not possible to determine whether these observations are epiphenomena or causal effects. Vaara et al. demonstrated an association between cumulative fluid overload (fluid accumulation \> 10%) prior to RRT initiation and increased risk for 90-day mortality; the 90-day mortality rate of patients with fluid overload was 59.2% versus 31.4% without (difference of 27.8%, *p* \<  0.001) \[[@CR25]\]. In an earlier analysis of the ICON database, we reported that fluid balances became negative after the third ICU day in survivors but remained positive in non-survivors and that higher cumulative fluid balance at day 3 after ICU admission was independently associated with an increase in the hazard of death \[[@CR26]\]. However, large randomized controlled trials have not shown a significant impact of fluid resuscitation strategy on clinical outcome or need for RRT \[[@CR27]\].

Our study has several strengths but also some limitations. Strengths include the large database with patients from around the world, providing external validity, and the collection of data during the ICU stay. Limitations include the complexity of elements associated with oliguria that cannot be separated out, for example, we were unable to assess the need for fluids or diuretics or to assess the impact of different vasopressors. Moreover, criteria for RRT were not pre-defined due to the study design. Thus, RRT may have been used for fluid overload, increased urea and creatinine concentrations, electrolyte abnormalities, severe acidosis, and any combination of these. Another limitation is the lack of pre-admission data regarding the length of oliguria prior to ICU admission or the underlying reason for oliguria as well as the lack of post-discharge data. The methods of monitoring urine output and assessing body weight also likely varied across centers and may have influenced the accuracy of measurements. Finally, we chose a definition of oliguria using a cut-off of urine output of 0.5 ml/kg/h, but this degree of urine output may in fact be adequate for some patients, e.g., the very obese and the very old.

Conclusion {#Sec8}
==========

In conclusion, the present study demonstrates that oliguria is a common occurrence in ICU patients, and suggests that it may have a relatively benign nature if only transient. For prognostic assessment, it is more the duration of oliguria and need for RRT than oliguria per se that are associated with a worse outcome.
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*Germany*: Alexianer Krefeld Gmbh (Stefan Arens); Charite Hochschulmedizin Berlin (Clemens Hoffmann); Charite-University-Hospital, Berlin (Magnus Kaffarnik); Diakoniekrankenhaus Henriettenstiftung Gmbh (Claus-Jorg Scharnofske); Elisabeth-Krankenhaus, Essen (Ingo Voigt); Harlaching Hospital, Munich Municipal Hospital Group (Claus Peckelsen); Helios St. Johannes Klinik (Matthias Weber); Hospital St. Georg Leipzig (Jochen Gille); Klinik Hennigsdorf Der Oberhavel Kliniken Gmbh (Andreas Lange); Klinik Tettnang (Georg Schoser); Klinikum "St. Georg" Leipzig (Armin Sablotzki); Klinikum Augsburg (Ulrich Jaschinski); Klinikum Augsburg (Andreas Bluethgen); Klinikum Bremen-Mitte (Frank Vogel); Klinikum Bremen-Ost (Andreas Tscheu); Klinikum Heidenheim (Thomas Fuchs); Klinikum Links Der Weser Gmbh (Michael Wattenberg); Klinikum Luedenscheid (Torsten Helmes); Krankenhaus Neuwerk (Stefan Scieszka); Marienkrankenhaus Schwerte (Matthias Heintz); Medical Centre Cologne Merheim (Samir Sakka); Schwarzwald-Baar Klinikum Villingen-Schwenningen (Johannes Kohler); St. Elisabeth Krankenhaus Köln-Hohenlind (Fritz Fiedler); St. Martinus Hospital Olpe (Matthias Danz); Uniklinikum Jena (Yasser Sakr); Universitätsklinikum Tübingen (Reimer Riessen); Universitätsmedizin Mainz (Thomas Kerz); University Hospital Aachen, CPACC (Alexander Kersten); University Hospital Aachen, DMIII (Frank Tacke); University Hospital Aachen, OIC (Gernot Marx); University Hospital Muenster (Thomas Volkert); University Medical Centre Freiburg (Axel Schmutz); University Medical Centre Hamburg-Eppendorf (Axel Nierhaus); University Medical Centre Hamburg-Eppendorf (Stefan Kluge); University Medicine Greifswald (Peter Abel); University of Duisburg-Essen (Rolf A Janosi); University of Freiburg (Stefan Utzolino); University clinic Ulm (Hendrik Bracht); Vivantes Klinikum Neukoelln (Susanne Toussaint)

*Greece*: Ahepa University Hospital (Maria Giannakou Peftoulidou); Athens University (Pavlos Myrianthefs); Athens University Medical School (Apostolos Armaganidis); Evangelismos Hospital (Christina Routsi); General Hospital of Chania, Crete (Angela Xini); Hippokration General Hospital, Thessaloniki (Eleni Mouloudi); General hospital of Velos (Ioannis Kokoris); Lamia General Hospital (George Kyriazopoulos); Naval and Veterans Hospital (Sawas Vlachos); Papanikolaou General Hospital (Athena Lavrentieva); University Hospital Alexandroupolis (Panagio Partala); University of Ioannina (George Nakos)

*Iceland*: Landspitali University Hospital (Alma Moller); Landspitali University Hospital Fossvogur (Sigurjon Ö Stefansson)

*Ireland*: Cork University Hospital (Joan Barry); Mercy University Hospital (Ruth A O'Leary); Mid Western Regional Hospital Complex (Catherine Motherway); Midland Regional Hospital Mullingar, Co Westmeath (Mohammad Faheem); St. Vincent's University Hospital (Eimhin Dunne); Tallaght Hospital (Maria Donnelly); University Hospital Galway (Torsten Konrad)

*Italy*: Anesthesiology and Intensive Care (Eleonora Bonora); AO Ospedale Niguarda Ca′ Granda (Carola Achilli); Azienda Ospedaliera Di Padova (Sandra Rossi); Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele (Giacomo Castiglione); Careggi Teaching Hospital (Adriano Peris); Clinicized Hospital SS Annunziata - Chieti (Daniela Albanese); Fondazione IRCCS Ca′ Granda Ospedale Maggiore Policlinico, Milano; University of Milan (Nino Stocchetti); H San Gerardo - Monza (Giuseppe Citerio); ICU "Ceccarini" Hospital Riccione (Lorella Mozzoni); IRCCS Centro Cardiologico Monzino (Erminio Sisillo); IRCCS Centro Di Riferimento Oncologico Della Basilicata (Pasquale De Negri); IRCCS Fondazione Ca′ Granda - Ospedale Maggiore Policlinico (Monica Savioli); Ospedale Belcolle Viterbo (Pietro Vecchiarelli); Ospedale Civile Maggiore - A.O.U.I Verona (Florin Puflea); Ospedale Civile Maggiore - A.O.U.I Verona (Vladimir Stankovic); Ospedale Di Circolo E Fondazione Macchi - Varese (Giulio Minoja); Ospedale Di Trento - Azienda Provinciale Per I Servizi Sanitari Della Provincia Autonoma Di Trento (Silvia Montibeller); Ospedale Orlandi (Plinio Calligaro); Ospedale Regionale U.Parini-Aosta (Raffaella Sorrentino); Ospedale San Donato Arezzo (Marco Feri); Ospedale San Raffaele (Massimo Zambon); Policlinico G.B. Rossi - A.O.U.I Verona (Elena Colombaroli); Policlinico University of Palermo (Antonino Giarratano); Santa Maria Degli Angeli Hospital (Tommaso Pellis); Saronno Hospital (Carlo Capra); Università Cattolica Del Sacro Cuore (Massimo Antonelli); University Catania, Italy (Antonino Gullo); University of Florence, Florence (Cosimo Chelazzi); University of Foggia (Antonella De Capraris); University of Milano-Bicocca, San Gerardo Hospital (Nicolo Patroniti); University of Modena (Massimo Girardis); University of Siena (Frederico Franchi); University of Trieste (Giorgio Berlot)

*Malta*: Mater Dei Hospital (Michael Buttigieg)

*Netherlands*: Albert Schweitzer Hospital (Hubert Ponssen); Antoni Van Leeuwenhoek Ziekenhuis (Julia Ten Cate); Atrium Medisch Centrum Parkstad (Laura Bormans); Bovenij Hospital (Satria Husada); Catharina Hospital Eindhoven (Marc Buise); Erasmus University Medical Centre (Ben Van Der Hoven); Martiniziekenhuis Groningen (Auke Reidinga); Medical Centre Leeuwarden (Michael Kuiper); Radboud University Nijmegen Medical Centre (Peter Pickkers); Slotervaart Ziekenhuis Amsterdam (Georg Kluge); Spaarne Ziekenhuis (Sylvia Den Boer); University Medical Centre Utrecht (Jozef Kesecioglu); Ziekenhuis Rijnstate (Henk Van Leeuwen)

*Norway*: Haukeland University Hospital (Hans Flaatten); St Olavs Hospital, Trondheim University Hospital (Skule Mo)

*Portugal*: Centro Hospitalar Cova Da Beira (Vitor Branco); Centro Hospitalar Do Porto (Fernando Rua); Centro Hospitalar Do Tâmega E Sousa (Estevao Lafuente); Centro Hospitalar Gaia/Espinho, Epe (Marta Sousa); Centro Hospitalar Médio Tejo (Nuno Catorze); Centro Hospitalar Tondela-Viseu (Maria Barros); Faro Hospital (Luis Pereira); Hospital Curry Cabral (Ana Vintém De Oliveira); Hospital Da Luz (Jose Gomes); Hospital De Egas Moniz - Chlo (Isable Gaspar); Hospital De Santo António, Centro Hospitalar Do Porto (Maria F Pereira); Hospital Divino Espírito Santo, Epe (Maria Cymbron); Hospital Espirito Santo - Évora Epe (Antonio Dias); Hospital Garcia Orta (Eduardo Almeida); Hospital Geral Centro Hospitalar E Universitario Coimbra (Sofia Beirao); Hospital Prof. Doutor Fernando Fonseca Epe (Isabel Serra); Hospital São Bernardo (Rosa Ribeiro); Hospital Sao Francisco Xavier, Chlo (Pedro Povoa); Instituto Portugues De Oncologia Francisco Gentil, Porto (Filomena Faria); Santa Maria Hospital (Zelia Costa-E-Silva); Serviço De Saúde Da Região Autonóma Da Madeira (Jose J Nóbrega); UCIP (Fatima Fernandes); ULS - Castelo Branco (Joao Gabriel)

*Slovenia*: General Hospital Celje (Gorazd Voga); General Hospital Izola (Erik Rupnik); General Hospital Novo Mesto (Lucka Kosec); Oncological Institute (Milena Kerin Povšic); Ukc Maribor (Irena Osojnik); University Clinic of Respiratory and Allergic Diseases (Viktorija Tomic); University Clinical Centre Maribor (Andreja Sinkovic)

*Spain*: CH Salamanca (Javier González); Clinic Hospital (Elizabeth Zavala); Complejo Hospitalario De Jaén (Jesus Pérez Valenzuela); Complejo Hospitalario De Toledo (Luis Marina); Complexo Hospitalario Universitario De Ourense (Pablo Vidal-Cortés); Complexo Hospitalario Universitario De Vigo (Pilar Posada); Corporación Sanitaria Parc Tauli (Ignacio Martin-Loeches); Cruz Roja Hospital (Noelia Muñoz Guillén); H Vall Hebron (Mercedes Palomar); HGGC Dr. Negrín (Jordi Sole-Violan); Hospital Clinic (Antoni Torres); Hospital Clinico San Carlos (Miguel A Gonzalez Gallego); Hospital Clínico Universitario De Valencia (Gerardo Aguilar); Hospital Clínico Universitario Lozano Blesa (Raquel Montoiro Allué); Hospital Clinico Valencia (Monica Argüeso); Hospital De La Ribera (Martin Parejo); Hospital De Sagunto (Manuel Palomo Navarro); Hospital De San Juan De Alicante (Anton Jose); Hospital De Torrejon De Ardoz (Nicholas Nin); Hospital Del Mar (Francisco Alvarez Lerma); Hospital Del Tajo (Oscar Martinez); Hospital General Universitario De Elche (Eva Tenza Lozano); Hospital General Universitario Gregorio Marañon (Sara Arenal López); Hospital General Universitario Gregorio Marañon (Maria J Perez Granda); Hospital General Universitario Santa Lucía (Salvador Moreno); Hospital Germans Trias I Pujol (Clara Llubia); Hospital Infanta Margarita (Carmen De La Fuente Martos); Hospital Infanta Sofia (Paloma Gonzalez-Arenas); Hospital J.M. Morales Meseguer (Noemi Llamas Fernández); Hospital J.M. Morales Meseguer (Bernard Gil Rueda); Hospital Marina Salu. Denia. Alicante (Isabel Estruch Pons); Hospital Nuestra Señora Del Prado, Talavera De La Reina, Toledo. España (Nieves Cruza); Hospital San Juan De Dios Aljarafe (Fernando Maroto); Hospital Sas of Jerez (Angel Estella); Hospital Son Llatzer (Ana Ferrer); Hospital Universitario Central De Asturias (Lisardo Iglesias Fraile); Hospital Universitario Central De Asturias (Brigida Quindos); Hospital Universitario De Alava, Santiago (Amaia Quintano); Hospital Universitario De Basurto, Bilbao (Maria T Tebar); Hospital Universitario de Getafe (Pablo Cardinal); Hospital Universitario De La Princesa (Antonio Reyes); Hospital Universitario de Tarragona Joan Xxiii (Alejandro Rodríguez); Hospital Universitario Del Henares (Ana Abella); Hospital Universitario Fundación Alcorcón (Santiago García Del Valle); Hospital Universitario La Paz (Santiago Yus); Hospital Universitario La Paz (Emilio Maseda); Hospital Universitario Rio Hortega (Jose A Berezo); Hospital Universitario San Cecilio (Granada) (Armando Tejero Pedregosa); Hospital Virgen Del Camino (Clara Laplaza); Mutua Terrassa University Hospital (Ricard Ferrer); Rão Hortega University Hospital (Jesus Rico-Feijoo); Servicio Andaluz De Salud (Marina Rodríguez); University Okalingaf Navarra (Pablo Monedero)

*Sweden*: Karolinska University Hospital And Karolinska Institute (Karin Eriksson); Sunderby Hospital, Luleå (Dan Lind)

*Switzerland*: Hôpital Intercantonal De La Broye (David Chabanel); Hôpital Neuchâtelois - La Chaux-De-Fonds (Hervé Zender); Lindenhofspital (Kuno Heer); Regionalspital Surselva Ilanz (Gr) Schweiz (Bernd Frankenberger); University Hospital Bern (Stephan Jakob); Zentrum Für Intensivmedizin (Alois Haller)

*United Kingdom*: Alexandra Hospital Redditch (Shiju Matthew); Blackpool Teaching Hospitals (Robert Downes); Brighton And Sussex University Hospitals (Casiano Barrera Groba); Cambridge University Hospitals NHS Foundation Trust (Andrew Johnston); Charing Cross Hospital (Roseanne Meacher); Chelsea & Westminster Hospital (Rick Keays); Christie Foundation Trust (Philip Haji-Michael); County Hospital, Lincoln (Chris Tyler); Craigavon Area Hospital (Andrew Ferguson); Cumberland Infirmary (Simon Jones); Darent Valley Hospital (David Tyl); Dorset County Hospital (Andrew Ball); Ealing Hospital NHS Trust (John Vogel); Glasgow Royal Infirmary (Malcolm Booth); Gloucester Royal Hospital (Paul Downie); The Great Western Hospital, Swindon (Malcolm Watters); Imperial College Healthcare NHS Trust (Stephen Brett); Ipswich Hospital NHS Trust (Marc Garfield); James Paget University Hospital NHS Foundation Trust (Lynn Everett); King's College Hospital (Sarah Heenen); King's Mill Hospital (Sandeep Dhir); Leeds Teaching Hospitals NHS Trust (Zoe Beardow); Lewisham Healthcare NHS Trust (Marthinus Mostert); Luton and Dunstable Hospital NHS Trust (Steve Brosnan); Medway Maritime Hospital (Nuno Pinto); Musgrove Park Hospital (Stephen Harris); Nevill Hall Hospital (Andy Summors); Pilgrim Hospital (Andrew Norton); Pinderfields Hospital, Mid Yorkshire NHS Trust (Alastair Rose); Plymouth Hospitals NHS Trust (Rebecca Appelboam); Princess Royal Hospital Telford (Omubo Davies); Royal Bournemouth Hospital (Emma Vickers); Royal Free Hampstead NHS Foundation Trust (Banwari Agarwal); Royal Glamorgan Hospital (Tamas Szakmany); Royal Hampshire County Hospital (Stephen Wimbush); Royal Liverpool University Hospital (Ingeborg Welters); Royal London Hospital, Barts Health NHS Trust (Rupert Pearse); Royal Shrewsbury Hospital (Robin Hollands); Royal Surrey County Hospital (Justin Kirk-Bayley); St Georges Healthcare (Nick Fletcher); Surrey & Sussex Healthcare Trust (Barbara Bray); University College Hospital (David Brealey); University Hospital of South Manchester (Peter Alexander); Western Infirmary (Steven Henderson); Whittington Hospital (Chris Hargreaves); Wirral University Teaching Hospital (Heather Black); Yeovil District Hospital (Kiran Gowda)
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